Mefloquine Improved Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus

被引:27
作者
Beppu, Minako [1 ]
Kawamoto, Michi [1 ]
Nukuzuma, Souichi [2 ]
Kohara, Nobuo [1 ]
机构
[1] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan
[2] Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan
关键词
progressive multifocal leukoencephalopathy; systemic lupus erythematosus; mefloquine; HIV;
D O I
10.2169/internalmedicine.51.6810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of a 67-year-old man with systemic lupus erythematosus who presented with progressive left hemiplegia. Although the cerebral spinal fluid (CSF) polymerase chain reaction (PCR) for the JC virus was negative, a brain biopsy confirmed the diagnosis of progressive multifocal leukoencephalopathy (PML). The tapering of prednisone and the use of cidofovir could not arrest the disease progression. Administration of mefloquine stopped the extension of the lesion, and resulted in obvious clinical improvement. The CSF nested PCR for the JC virus also became negative. This widely used drug should be tried for the treatment of non-HIV PML.
引用
收藏
页码:1245 / 1247
页数:3
相关论文
共 12 条
  • [1] Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy
    Albrecht, H
    Hoffmann, C
    Degen, O
    Stoehr, A
    Plettenberg, A
    Mertenskötter, T
    Eggers, C
    Stellbrink, HJ
    [J]. AIDS, 1998, 12 (10) : 1149 - 1154
  • [2] Incidence of progressive multifocal leukoencephalopathy in patients without HIV
    Amend, K. L.
    Turnbull, B.
    Foskett, N.
    Napalkov, P.
    Kurth, T.
    Seeger, J.
    [J]. NEUROLOGY, 2010, 75 (15) : 1326 - 1332
  • [3] Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro
    Brickelmaier, Margot
    Lugovskoy, Alexey
    Kartikeyan, Ramya
    Reviriego-Mendoza, Marta M.
    Allaire, Norm
    Simon, Kenneth
    Frisque, Richard J.
    Gorelik, Leonid
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1840 - 1849
  • [4] The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology
    Cinque, P
    Koralnik, IJ
    Clifford, DB
    [J]. JOURNAL OF NEUROVIROLOGY, 2003, 9 (Suppl 1) : 88 - 92
  • [5] Friedman R, 2011, Neurology Today, V11, P8, DOI [10.1097/01.NT.0000397959.27386.55, DOI 10.1097/01.NT.0000397959.27386.55]
  • [6] Mefloquine in the treatment of progressive multifocal leukoencephalopathy
    Gofton, T. E.
    Al-Khotani, A.
    O'Farrell, B.
    Ang, L. C.
    McLachlan, R. S.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (04) : 452 - 455
  • [7] Hirsch Hans H., 1998, Clin Microbiol Infect, V4, P577, DOI 10.1111/j.1469-0691.1998.tb00040.x
  • [8] Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus
    Itoh, K
    Kano, T
    Nagashio, C
    Mimori, A
    Kinoshita, M
    Sumiya, M
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 1020 - 1022
  • [9] Mefloquine Treatment in a Patient Suffering from Progressive Multifocal Leukoencephalopathy after Umbilical Cord Blood Transplant
    Kishida, Shuji
    Tanaka, Kozue
    [J]. INTERNAL MEDICINE, 2010, 49 (22) : 2509 - 2513
  • [10] Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?
    Molloy, Eamonn S.
    Calabrese, Leonard H.
    [J]. AUTOIMMUNITY REVIEWS, 2008, 8 (02) : 144 - 146